Search research articles
Contact Us
Filters
Showing results (31-40 of 100) with videos related to
Page
of 10
Sort By:
British Journal of Cancer
|
October 1, 1990
Predicting response to chemotherapy for patients with epithelial ovarian cancer using urinary polyamine excretion patterns
F G Lawton, M Griffin, J A Slack, et al.
The British Journal of Radiology
|
November 1, 1981
The role of abdominal computed tomography in lymphoma following treatment
G Blackledge, H Mamtora, D Crowther, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
EORTC joint ventures in quality control: treatment-related variables and data acquisition in chemotherapy trials
K Vantongelen, W Steward, G Blackledge, et al.
Lancet (London, England)
|
March 28, 1987
HPV 16 DNA in normal and malignant cervical epithelium: implications for the aetiology and behaviour of cervical neoplasia
C A Meanwell, M F Cox, G Blackledge, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1985
Sequential chemotherapy for advanced epithelial ovarian cancer: platinum combination cytoreduction followed by cyclophosphamide consolidation
F Lawton, G Blackledge, H Buckley, et al.
The Biochemical Journal
|
October 15, 1982
Flow cytometric analysis of lectin binding to human peripheral blood lymphocytes
G Blackledge, B Vose, A J Morris, et al.
European Journal of Cancer & Clinical Oncology
|
July 1, 1987
Speed of response to platinum-based chemotherapy: implications for the management of epithelial ovarian cancer
F G Lawton, K A Kelly, L J Sant Cassia, et al.
Journal of Surgical Oncology
|
September 1, 1990
Feasibility and outcome of complete secondary tumor resection for patients with advanced ovarian cancer
F Lawton, D Luesley, C Redman, et al.
European Journal of Cancer & Clinical Oncology
|
July 1, 1986
Prediction of ifosfamide/mesna associated encephalopathy
C A Meanwell, A E Blake, K A Kelly, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
A phase II study of ifosfamide in endometrial cancer
C Barton, E J Buxton, G Blackledge, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 100) with videos related to
Sort By:
Page
of 10
British Journal of Cancer
|
October 1, 1990
Predicting response to chemotherapy for patients with epithelial ovarian cancer using urinary polyamine excretion patterns
F G Lawton, M Griffin, J A Slack, et al.
The British Journal of Radiology
|
November 1, 1981
The role of abdominal computed tomography in lymphoma following treatment
G Blackledge, H Mamtora, D Crowther, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
EORTC joint ventures in quality control: treatment-related variables and data acquisition in chemotherapy trials
K Vantongelen, W Steward, G Blackledge, et al.
Lancet (London, England)
|
March 28, 1987
HPV 16 DNA in normal and malignant cervical epithelium: implications for the aetiology and behaviour of cervical neoplasia
C A Meanwell, M F Cox, G Blackledge, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1985
Sequential chemotherapy for advanced epithelial ovarian cancer: platinum combination cytoreduction followed by cyclophosphamide consolidation
F Lawton, G Blackledge, H Buckley, et al.
The Biochemical Journal
|
October 15, 1982
Flow cytometric analysis of lectin binding to human peripheral blood lymphocytes
G Blackledge, B Vose, A J Morris, et al.
European Journal of Cancer & Clinical Oncology
|
July 1, 1987
Speed of response to platinum-based chemotherapy: implications for the management of epithelial ovarian cancer
F G Lawton, K A Kelly, L J Sant Cassia, et al.
Journal of Surgical Oncology
|
September 1, 1990
Feasibility and outcome of complete secondary tumor resection for patients with advanced ovarian cancer
F Lawton, D Luesley, C Redman, et al.
European Journal of Cancer & Clinical Oncology
|
July 1, 1986
Prediction of ifosfamide/mesna associated encephalopathy
C A Meanwell, A E Blake, K A Kelly, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
A phase II study of ifosfamide in endometrial cancer
C Barton, E J Buxton, G Blackledge, et al.
Page
of 10